BAYERCROP - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.5
| Stock Code | BAYERCROP | Market Cap | 21,411 Cr. | Current Price | 4,764 ₹ | High / Low | 6,540 ₹ |
| Stock P/E | 31.9 | Book Value | 695 ₹ | Dividend Yield | 2.62 % | ROCE | 24.8 % |
| ROE | 20.0 % | Face Value | 10.0 ₹ | DMA 50 | 4,682 ₹ | DMA 200 | 4,843 ₹ |
| Chg in FII Hold | 0.05 % | Chg in DII Hold | 0.42 % | PAT Qtr | 95.7 Cr. | PAT Prev Qtr | 153 Cr. |
| RSI | 52.8 | MACD | 14.6 | Volume | 17,150 | Avg Vol 1Wk | 16,810 |
| Low price | 4,273 ₹ | High price | 6,540 ₹ | PEG Ratio | -17.6 | Debt to equity | 0.03 |
| 52w Index | 21.7 % | Qtr Profit Var | 180 % | EPS | 149 ₹ | Industry PE | 25.0 |
📊 Financials: BAYERCROP shows strong efficiency with ROCE at 24.8% and ROE at 20.0%. EPS stands at ₹149, supported by a debt-to-equity ratio of 0.03, reflecting financial stability. However, quarterly PAT dropped to ₹95.7 Cr. from ₹153 Cr., highlighting earnings volatility. Dividend yield at 2.62% adds shareholder value, but profit consistency remains a concern.
💹 Valuation: The stock trades at a P/E of 31.9 compared to the industry average of 25.0, indicating stretched valuations. The PEG ratio of -17.6 highlights weak growth prospects relative to valuation. Book value is ₹695, giving a P/B ratio of ~6.9, which is expensive. Current price of ₹4,764 is near 50 DMA (₹4,682) and 200 DMA (₹4,843), showing neutral technical positioning.
🏢 Business Model & Competitive Advantage: BAYERCROP operates in agrochemicals and crop science, benefiting from strong brand presence, diversified product portfolio, and institutional support. Its competitive advantage lies in efficiency and low leverage. However, earnings volatility and stretched valuations reduce attractiveness for fresh entry.
🎯 Entry Zone: A favorable entry zone lies near ₹4,600–₹4,700 (close to DMA support). Current price of ₹4,764 is slightly above comfort levels, suggesting cautious positioning for fresh entry.
📈 Long-Term Holding Guidance: Suitable for long-term investors given strong fundamentals and dividend yield. Holding is justified with partial allocation, while profit booking near ₹4,900–₹5,000 resistance is advisable.
Positive
- Strong ROCE (24.8%) and ROE (20.0%)
- EPS at ₹149 supports earnings base
- Debt-to-equity ratio of 0.03 indicates financial stability
- Dividend yield at 2.62% adds shareholder value
- Institutional inflows (FII +0.05%, DII +0.42%) show confidence
Limitation
- High P/E (31.9) vs industry average (25.0)
- P/B ratio ~6.9 indicates premium valuation
- Negative PEG ratio (-17.6) highlights weak growth prospects
- Quarterly PAT decline shows earnings volatility
Company Negative News
- Quarterly PAT dropped to ₹95.7 Cr. from ₹153 Cr.
- Stock trading far below 52-week high (₹6,540)
Company Positive News
- Dividend yield at 2.62% supports investors
- Institutional inflows (FII/DII) increased slightly
- Technical indicators (RSI 52.8, MACD 14.6) show neutral-to-positive momentum
Industry
- Agrochemical sector trades at industry P/E of 25.0
- Sector outlook remains stable with demand linked to agriculture cycles
Conclusion
⚖️ BAYERCROP is a fundamentally strong company with high efficiency, low debt, and dividend support, but faces earnings volatility and stretched valuations. Entry near ₹4,600–₹4,700 offers favorable risk-reward. Long-term holding is justified with partial allocation, while profit booking near ₹4,900–₹5,000 is recommended.